WithdrawnNot applicableNCT04329442

Accelerated PrEP Access for Black MSM and TW

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Chicago
Principal Investigator
Darnell N Motley, PhD
University of Chicago
Intervention
Emtricitabine / Tenofovir Disoproxil Oral Tablet(drug)
Eligibility
18-24 years · MALE
Timeline
20202021

Collaborators

Planned Parenthood Great Plains

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04329442 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials